$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

위암 및 위선종에서 내시경절제술 조직의 병리 판독
Pathological Interpretation of Gastric Tumors in Endoscopic Submucosal Dissection 원문보기

Journal of digestive cancer research, v.11 no.1, 2023년, pp.15 - 20  

김정연 (인제대학교 의과대학 상계백병원 병리과)

Abstract AI-Helper 아이콘AI-Helper

Endoscopic submucosal dissection (ESD) is a minimally invasive and effective treatment for early gastric cancer. The criteria for determining the suitability and success of ESD have expanded, with changes in the histopathological classification of gastric carcinoma, including results from molecular ...

주제어

참고문헌 (31)

  1. Jung, Kyu-Won, Won, Young-Joo, Hong, Seri, Kong, Hyun-Joo, Im, Jeong-Soo, Seo, Hong Gwan. Prediction of Cancer Incidence and Mortality in Korea, 2021. Cancer research and treatment : official journal of Korean Cancer Association, vol.53, no.2, 316-322.

  2. Hatta, Waku, Gotoda, Takuji, Oyama, Tsuneo, Kawata, Noboru, Takahashi, Akiko, Yoshifuku, Yoshikazu, Hoteya, Shu, Nakagawa, Masahiro, Hirano, Masaaki, Esaki, Mitsuru, Matsuda, Mitsuru, Ohnita, Ken, Yamanouchi, Kohei, Yoshida, Motoyuki, Dohi, Osamu, Takada, Jun, Tanaka, Keiko, Yamada, Shinya, Tsuji, Tsuyotoshi, Ito, Hirotaka, Hayashi, Yoshiaki, Nakamura, Tomohiro, Shimosegawa, Tooru. Correction: A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: “eCura system”. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.114, no.12, 1925-1926.

  3. Guideline Committee of the Korean Gastric Cancer Association (KGCA) and Development Working Group & Review Panel. Erratum: Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. Journal of gastric cancer : jgc, vol.19, no.3, 372-373.

  4. Kushima, R.. The updated WHO classification of digestive system tumours-gastric adenocarcinoma and dysplasia. Der Pathologe, vol.43, no.1, 8-15.

  5. 10.1002/9781118695647.ch2 

  6. Muro, Kei, Chung, Hyun Cheol, Shankaran, Veena, Geva, Ravit, Catenacci, Daniel, Gupta, Shilpa, Eder, Joseph Paul, Golan, Talia, Le, Dung T, Burtness, Barbara, McRee, Autumn J, Lin, Chia-Chi, Pathiraja, Kumudu, Lunceford, Jared, Emancipator, Kenneth, Juco, Jonathan, Koshiji, Minori, Bang, Yung-Jue. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. The Lancet. Oncology, vol.17, no.6, 717-726.

  7. Bang, Yung-Jue, Van Cutsem, Eric, Feyereislova, Andrea, Chung, Hyun C, Shen, Lin, Sawaki, Akira, Lordick, Florian, Ohtsu, Atsushi, Omuro, Yasushi, Satoh, Taroh, Aprile, Giuseppe, Kulikov, Evgeny, Hill, Julie, Lehle, Michaela, Rüschoff, Josef, Kang, Yoon-Koo. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. The Lancet, vol.376, no.9742, 687-697.

  8. Park, Young Soo, Kook, Myeong-Cherl, Kim, Baek-hui, Lee, Hye Seung, Kang, Dong-Wook, Gu, Mi-Jin, Shin, Ok Ran, Choi, Younghee, Lee, Wonae, Kim, Hyunki, Song, In Hye, Kim, Kyoung-Mee, Kim, Hee Sung, Kang, Guhyun, Park, Do Youn, Jin, So-Young, Kim, Joon Mee, Choi, Yoon Jung, Chang, Hee Kyung, Ahn, Soomin, Chang, Mee Soo, Han, Song-Hee, Kwak, Yoonjin, Seo, An Na, Lee, Sung Hak, Cho, Mee-Yon. A standardized pathology report for gastric cancer: 2nd edition. Journal of pathology and translational medicine : JPTM, vol.57, no.1, 1-27.

  9. Seo, Ho Seok, Lee, Go Eun, Kang, Min Gon, Han, Kyu Hun, Jung, Eun Sun, Song, Kyo Young. Mixed Histology Is a Risk Factor for Lymph Node Metastasis in Early Gastric Cancer. The Journal of surgical research, vol.236, 271-277.

  10. Horiuchi, Yusuke, Ida, Satoshi, Yamamoto, Noriko, Nunobe, Souya, Ishizuka, Naoki, Yoshimizu, Shoichi, Ishiyama, Akiyoshi, Yoshio, Toshiyuki, Hirasawa, Toshiaki, Tsuchida, Tomohiro, Kumagai, Koshi, Ohashi, Manabu, Sano, Takeshi, Fujisaki, Junko. Feasibility of further expansion of the indications for endoscopic submucosal dissection in undifferentiated-type early gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol.23, no.2, 285-292.

  11. Lee, I.S., Lee, S., Park, Y.S., Gong, C.S., Yook, J.H., Kim, B.S.. Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis. Surgical oncology, vol.26, no.1, 8-12.

  12. Guo, Chun Guang, Zhao, Dong Bing, Liu, Qian, Zhou, Zhi Xiang, Zhao, Ping, Wang, Gui Qi, Cai, Jian Qiang. Risk Factors for Lymph Node Metastasis in Early Gastric Cancer with Signet Ring Cell Carcinoma. Journal of gastrointestinal surgery : official journal of the society for surgery of the alimentary tract, vol.19, no.11, 1958-1965.

  13. Kim, Yon Hee, Park, Ji Hye, Park, Cheol Keun, Kim, Jie-Hyun, Lee, Sang Kil, Lee, Yong Chan, Noh, Sung Hoon, Kim, Hyunki. Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol.20, no.4, 583-590.

  14. Ma, Dae Won, Lee, Seok Joo, Kook, Myeong-Cherl, Park, Do Youn, Ahn, Sangjeong, Ryu, Keun Won, Choi, Il Ju, Noh, Sung Hoon, Kim, Hyunki, Lee, Yong Chan, Kim, Jie-Hyun. The Suggestion of Revised Criteria for Endoscopic Resection of Differentiated-Type Submucosal Gastric Cancer. Annals of surgical oncology, vol.27, no.3, 795-801.

  15. Choi, Ji Young, Park, Young Soo, Jung, Hwoon-Yong, Son, Da Hye, Ahn, Ji Yong, Han, Seungbong, Lim, Hyun, Choi, Kwi-Sook, Lee, Jeong Hoon, Kim, Do Hoon, Choi, Kee Don, Song, Ho June, Lee, Gin Hyug, Kim, Jin-Ho. Identifying predictors of lymph node metastasis after endoscopic resection in patients with minute submucosal cancer of the stomach. Surgical endoscopy : and other interventional techniques, vol.29, no.6, 1476-1483.

  16. Choi, Il Ju, Kook, Myeong-Cherl, Kim, Young-Il, Cho, Soo-Jeong, Lee, Jong Yeul, Kim, Chan Gyoo, Park, Boram, Nam, Byung-Ho. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. The New England journal of medicine, vol.378, no.12, 1085-1095.

  17. Ono, Hiroyuki, Yao, Kenshi, Fujishiro, Mitsuhiro, Oda, Ichiro, Uedo, Noriya, Nimura, Satoshi, Yahagi, Naohisa, Iishi, Hiroyasu, Oka, Masashi, Ajioka, Yoichi, Fujimoto, Kazuma. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, vol.33, no.1, 4-20.

  18. Comprehensive molecular characterization of gastric adenocarcinoma. Nature, vol.513, no.7517, 202-209.

  19. Cristescu, Razvan, Lee, Jeeyun, Nebozhyn, Michael, Kim, Kyoung-Mee, Ting, Jason C, Wong, Swee Seong, Liu, Jiangang, Yue, Yong Gang, Wang, Jian, Yu, Kun, Ye, Xiang S, Do, In-Gu, Liu, Shawn, Gong, Lara, Fu, Jake, Jin, Jason Gang, Choi, Min Gew, Sohn, Tae Sung, Lee, Joon Ho, Bae, Jae Moon, Kim, Seung Tae, Park, Se Hoon, Sohn, Insuk, Jung, Sin-Ho, Tan, Patrick, Chen, Ronghua, Hardwick, James, Kang, Won Ki, Ayers, Mark, Hongyue, Dai, Reinhard, Christoph, Loboda, Andrey, Kim, Sung, Aggarwal, Amit. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature medicine, vol.21, no.5, 449-456.

  20. Van Cutsem, Eric, Bang, Yung-Jue, Feng-yi, Feng, Xu, Jian M., Lee, Keun-Wook, Jiao, Shun-Chang, Chong, Jorge León, López-Sanchez, Roberto I., Price, Timothy, Gladkov, Oleg, Stoss, Oliver, Hill, Julie, Ng, Vivian, Lehle, Michaela, Thomas, Marlene, Kiermaier, Astrid, Rüschoff, Josef. HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol.18, no.3, 476-484.

  21. Lee, H.E., Park, K.U., Yoo, S.B., Nam, S.K., Park, D.J., Kim, H.H., Lee, H.S.. Clinical significance of intratumoral HER2 heterogeneity in gastric cancer. European journal of cancer, vol.49, no.6, 1448-1457.

  22. Kim, Min A, Lee, Hyuk-Joon, Yang, Han-Kwang, Bang, Yung-Jue, Kim, Woo Ho. Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma. Histopathology, vol.59, no.5, 822-831.

  23. Kochi, Mitsugu, Fujii, Masashi, Masuda, Shinobu, Kanamori, Noriaki, Mihara, Yoshiaki, Funada, Tomoya, Tamegai, Hidenori, Watanabe, Megumu, Suda, Hiroshi, Takayama, Tadatoshi. Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes. Diagnostic pathology, vol.8, 191-191.

  24. Ahn, Sangjeong, Lee, So-Jeong, Kim, Yonugkeum, Kim, Ahrong, Shin, Nari, Choi, Kyung Un, Lee, Chang-Hun, Huh, Gi Yeong, Kim, Kyong-Mee, Setia, Namrata, Lauwers, Gregory Y., Park, Do Youn. High-throughput Protein and mRNA Expression–based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications. The American journal of surgical pathology, vol.41, no.1, 106-115.

  25. Choi, Yoon Young, Kim, Hyunki, Shin, Su-Jin, Kim, Ha Yan, Lee, Jinae, Yang, Han-Kwang, Kim, Woo Ho, Kim, Young-Woo, Kook, Myeong-Cherl, Park, Young Kyu, Kim, Hyung-Ho, Lee, Hye Seung, Lee, Kyung Hee, Gu, Mi Jin, Choi, Seung Ho, Hong, SoonWon, Kim, Jong Won, Hyung, Woo Jin, Noh, Sung Hoon, Cheong, Jae-Ho. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer : Post Hoc Analysis of the CLASSIC Randomized Controlled study. Annals of surgery, vol.270, no.2, 309-316.

  26. Le, Dung T., Durham, Jennifer N., Smith, Kellie N., Wang, Hao, Bartlett, Bjarne R., Aulakh, Laveet K., Lu, Steve, Kemberling, Holly, Wilt, Cara, Luber, Brandon S., Wong, Fay, Azad, Nilofer S., Rucki, Agnieszka A., Laheru, Dan, Donehower, Ross, Zaheer, Atif, Fisher, George A., Crocenzi, Todd S., Lee, James J., Greten, Tim F., Duffy, Austin G., Ciombor, Kristen K., Eyring, Aleksandra D., Lam, Bao H., Joe, Andrew, Kang, S. Peter, Holdhoff, Matthias, Danilova, Ludmila, Cope, Leslie, Meyer, Christian, Zhou, Shibin, Goldberg, Richard M., Armstrong, Deborah K., Bever, Katherine M., Fader, Amanda N., Taube, Janis, Housseau, Franck, Spetzler, David, Xiao, Nianqing, Pardoll, Drew M., Papadopoulos, Nickolas, Kinzler, Kenneth W., Eshleman, James R., Vogelstein, Bert, Anders, Robert A., Diaz Jr., Luis A.. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science, vol.357, no.6349, 409-413.

  27. Park, Ji Hye, Kim, Eun Kyung, Kim, Yon Hee, Kim, Jie-Hyun, Bae, Yoon Sung, Lee, Yong Chan, Cheong, Jae-Ho, Noh, Sung Hoon, Kim, Hyunki. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol.19, no.4, 1041-1051.

  28. Cheng, Yuqing, Zhou, Xiaoli, Xu, Kequn, Huang, Jin, Huang, Qin. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma. BMC gastroenterology, vol.20, no.1, 273-.

  29. Kim, Seung Tae, Cristescu, Razvan, Bass, Adam J., Kim, Kyoung-Mee, Odegaard, Justin I., Kim, Kyung, Liu, Xiao Qiao, Sher, Xinwei, Jung, Hun, Lee, Mijin, Lee, Sujin, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Lee, Hyuk, Choi, Mingew, Talasaz, AmirAli, Kang, Peter Soonmo, Cheng, Jonathan, Loboda, Andrey, Lee, Jeeyun, Kang, Won Ki. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nature medicine, vol.24, no.9, 1449-1458.

  30. Incomplete Conflict of Interest Disclosures. JAMA oncology, vol.5, no.4, 579-.

  31. Janjigian, Yelena Y, Shitara, Kohei, Moehler, Markus, Garrido, Marcelo, Salman, Pamela, Shen, Lin, Wyrwicz, Lucjan, Yamaguchi, Kensei, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda, Liu, Tianshu, Schenker, Michael, Yanez, Patricio, Tehfe, Mustapha, Kowalyszyn, Ruben, Karamouzis, Michalis V, Bruges, Ricardo, Zander, Thomas, Pazo-Cid, Roberto, Hitre, Erika, Feeney, Kynan, Cleary, James M, Poulart, Valerie, Cullen, Dana, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. The Lancet, vol.398, no.10294, 27-40.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로